HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wen-Fang Xu Selected Research

Imides

6/2010Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
11/2008Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wen-Fang Xu Research Topics

Disease

12Neoplasms (Cancer)
12/2015 - 06/2006
7Carcinoma (Carcinomatosis)
07/2014 - 06/2006
4Neoplasm Metastasis (Metastasis)
06/2010 - 06/2006
2Hepatocellular Carcinoma (Hepatoma)
12/2015 - 07/2007
2Leukemia
02/2012 - 01/2010
2Pathologic Processes
04/2008 - 01/2008
2Cardiovascular Diseases (Cardiovascular Disease)
04/2008 - 01/2008
1Cytomegalovirus Infections (Inclusion Disease)
10/2018
1Infections
10/2018
1Liver Neoplasms (Liver Cancer)
12/2015
1Acquired Immunodeficiency Syndrome (AIDS)
02/2014
1Acute Promyelocytic Leukemia
02/2012
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2012
1Measles
12/2010
1Viral Pneumonia
12/2010
1Bacterial Pneumonia
12/2010
1Chronic Pain
01/2010
1Human Influenza (Influenza)
10/2009
1Wounds and Injuries (Trauma)
11/2008
1Lewis Lung Carcinoma
11/2008
1Body Weight (Weight, Body)
07/2007
1Breast Neoplasms (Breast Cancer)
10/2006

Drug/Important Bio-Agent (IBA)

5CD13 Antigens (Alanine Aminopeptidase)IBA
12/2015 - 01/2010
5Matrix Metalloproteinases (MMPs)IBA
11/2008 - 06/2006
3ubenimexIBA
09/2011 - 01/2010
2Fluorouracil (Carac)FDA LinkGeneric
12/2015 - 07/2014
2EstersIBA
02/2012 - 09/2011
2ImidesIBA
06/2010 - 11/2008
2Matrix Metalloproteinase InhibitorsIBA
01/2008 - 06/2006
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2006 - 06/2006
1Immunoglobulins (Immunoglobulin)IBA
10/2018
1ValganciclovirFDA Link
10/2018
1Ganciclovir (Cytovene)FDA LinkGeneric
10/2018
1VaccinesIBA
10/2018
1DNA (Deoxyribonucleic Acid)IBA
10/2018
1ProdrugsIBA
07/2014
1NGR peptideIBA
07/2014
1Phosphatidylinositols (Phosphatidylinositol)IBA
10/2012
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2012
1TensinsIBA
10/2012
1Sorafenib (BAY 43-9006)FDA Link
09/2012
1Phosphotransferases (Kinase)IBA
09/2012
1Tretinoin (Retinoic Acid)FDA LinkGeneric
02/2012
1Caspase 3 (Caspase-3)IBA
02/2012
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
02/2012
1Caspase 9IBA
02/2012
1tamibaroteneIBA
02/2012
1C-Reactive ProteinIBA
12/2010
12- amino- N- (1- (2- (hydroxyamino)- 2- oxoethyl)- 2,6- dioxopiperidin- 3- yl)- 3- phenylpropanamideIBA
06/2010
1Peptide Hydrolases (Proteases)FDA Link
06/2010
1PeptidomimeticsIBA
06/2010
1TuftsinIBA
01/2010
1Analgesics (Analgesic Drugs)IBA
01/2010
1aminopeptidase BIBA
01/2010
1Opioid Peptides (Opioid Peptide)IBA
01/2010
1Neuraminidase (Sialidase)IBA
10/2009
1GelatinIBA
11/2008
1methyl 6- (benzyloxycarbonylamino)- 2- (2- (2,6- dioxo- 3- (3,4,5- trimethoxybenzamido)piperidin- 1- yl)acetamido)hexanoateIBA
11/2008
1Collagen Type IV (Type IV Collagen)IBA
11/2008
1antineoplaston A10 (A 10)IBA
07/2007
1N3-o-toluyl-fluorouracilIBA
11/2006
1atofludingIBA
11/2006
1GelatinasesIBA
10/2006
1pyrrolidineIBA
10/2006
1EnzymesIBA
06/2006

Therapy/Procedure

2Therapeutics
04/2008 - 01/2008
1Highly Active Antiretroviral Therapy (HAART)
02/2014
1Oral Administration
07/2007